TP53 and breast carcinoma: In a subsequent analysis of the same cohort [31], p53 immunopositivity in benign breast tissue was associated with a 2-fold increase in the risk of subsequent breast cancer, whereas the presence of any type of p53 nucleotide change in the benign tissue was not associated with altered risk.